{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:35:40Z","timestamp":1789014940598,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2002,4,1]],"date-time":"2002-04-01T00:00:00Z","timestamp":1017619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2002,4]]},"DOI":"10.1053\/berh.2001.0223","type":"journal-article","created":{"date-parts":[[2002,10,28]],"date-time":"2002-10-28T17:40:27Z","timestamp":1035826827000},"page":"229-244","source":"Crossref","is-referenced-by-count":58,"title":["Diagnosis and management of patients with neuropsychiatric systemic lupus erythematosus (NPSLE)"],"prefix":"10.1053","volume":"16","author":[{"given":"David","family":"Hermosillo-Romo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Brey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/berh.2001.0223_RF1","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F","volume":"42","year":"1999","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/096120339700600304","article-title":"Vasculitis in systemic lupus erythematosus","volume":"6","author":"Drenkard","year":"1997","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF3","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-196807000-00002","article-title":"The neurologic manifestation of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature","volume":"47","author":"Johnson","year":"1968","journal-title":"Medicine"},{"key":"10.1053\/berh.2001.0223_RF4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0049-0172(79)80009-8","article-title":"Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955\u20131977","volume":"8","author":"Ellis","year":"1979","journal-title":"Seminars in Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0733-8619(05)70172-9","article-title":"Central nervous system infections: disorders that mimic central nervous system infections","volume":"17","author":"De Marcaida","year":"1999","journal-title":"Neurologic Clinics"},{"key":"10.1053\/berh.2001.0223_RF6","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1002\/1529-0131(199910)42:10<2026::AID-ANR2>3.0.CO;2-J","article-title":"Neuroimaging in neuropsychiatric systemic lupus erythematosus","volume":"42","author":"Sibbitt","year":"1999","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF7","first-page":"680","article-title":"Association between clinical factors, socio-economic status, and organ damage in recent onset systemic lupus erythematosus","volume":"27","author":"Rivest","year":"2000","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF8","first-page":"S35","article-title":"Prevalence of neuropsychiatric syndromes in patients with systemic lupus erythematosus","volume":"10","author":"Sanna","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF9","first-page":"S33","article-title":"Neuropsychiatric lupus syndromes (NPSLE): Prevalence using standardized definitions","volume":"10","author":"Brey","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF10","first-page":"S32","article-title":"The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes: Analysis of 527 patients","volume":"10","author":"Costallat","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/qjmed\/93.3.169","article-title":"Risk factors for central nervous system involvement in systemic lupus erythematosus","volume":"93","author":"Karassa","year":"2000","journal-title":"Quarterly Journal of Medicine"},{"key":"10.1053\/berh.2001.0223_RF12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1212\/WNL.42.9.1649","article-title":"Central nervous system disease in patients with systemic lupus erythematosus","volume":"42","author":"Futrell","year":"1992","journal-title":"Neurology"},{"key":"10.1053\/berh.2001.0223_RF13","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1177\/096120339900800606","article-title":"The association between the antiphospholipid antibody syndrome and neuropsychological impairment in SLE","volume":"8","author":"Whitelaw","year":"1999","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1191\/096120399678847344","article-title":"Central nervous system involvement in systemic lupus erythematosus patients without overt neuropsychiatric manifestations","volume":"8","author":"Sabbadini","year":"1999","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s004150050583","article-title":"Cognitive impairment in systemic lupus erythematosus: a follow up study","volume":"247","author":"Carlomagno","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1053\/berh.2001.0223_RF16","first-page":"S35","article-title":"Neuropsychological function in SLE: a five-year longitudinal study","volume":"10","author":"Waterloo","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF17","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/1529-0131(199904)42:4<728::AID-ANR16>3.0.CO;2-O","article-title":"A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus","volume":"42","author":"Hanly","year":"1999","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF18","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/1529-0131(199904)42:4<735::AID-ANR17>3.0.CO;2-L","article-title":"A longitudinal analysis of anticardiolipin antibody levels and cognitive functioning in systemic lupus erythematosus","volume":"42","author":"Menon","year":"1999","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF19","first-page":"S33","article-title":"Validating repeatable neuropsychological battery for hispanic SLE patients","volume":"10","author":"Holliday","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF20","first-page":"232","article-title":"Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus","volume":"10","author":"Glanz","year":"1997","journal-title":"Neuropsychiatry, Neuropsychology, and Behavioral Neurology"},{"key":"10.1053\/berh.2001.0223_RF21","first-page":"S51","article-title":"Autoantibody contributions to cognitive function in SLE","volume":"10","author":"Hermosillo","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF22","first-page":"305","article-title":"Evoked potential study and radiological findings in patients with systemic lupus erythematosus","volume":"39","author":"Fierro","year":"1999","journal-title":"Electromyography and Clinical Neurophysiology"},{"key":"10.1053\/berh.2001.0223_RF23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000008067","article-title":"Decreased regional metabolic rate for glucose in systemic lupus erythematosus patients with psychiatric symptoms","volume":"42","author":"Komatsu","year":"1999","journal-title":"European Neurology"},{"key":"10.1053\/berh.2001.0223_RF24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1136\/ard.59.2.99","article-title":"The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease","volume":"59","author":"Tzioufas","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2001.0223_RF25","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1002\/art.1780391109","article-title":"Ribosomal P antibodies in systemic lupus erythematosus","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF26","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1002\/1529-0131(199810)41:10<1819::AID-ART14>3.0.CO;2-Y","article-title":"Differential roles on the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus","volume":"41","author":"Isshi","year":"1998","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF27","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"1994"},{"key":"10.1053\/berh.2001.0223_RF28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF02597440","article-title":"Adverse neurologic effects of glucocorticosteroids","volume":"6","author":"Lacomis","year":"1991","journal-title":"Journal of General Internal Medicine"},{"key":"10.1053\/berh.2001.0223_RF29","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/archinte.1985.00360100105017","article-title":"Cerebrospinal fluid IgM, IgA, and IgG indexes in systemic lupus erythematosus","volume":"145","author":"Hirohata","year":"1985","journal-title":"Archives of Internal Medicine"},{"key":"10.1053\/berh.2001.0223_RF30","series-title":"Lexicon of Psychiatry, Neurology, and the Neurosciences","author":"Ayd","year":"1995"},{"key":"10.1053\/berh.2001.0223_RF31","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1164\/ajrccm\/147.2.471","article-title":"Psychologic side effects of therapy with corticosteroids","volume":"147","author":"Milgrom","year":"1993","journal-title":"American Review of Respiratory Diseases"},{"key":"10.1053\/berh.2001.0223_RF32","first-page":"406","volume":"3","year":"1971","journal-title":"Seminars in Psychiatry"},{"key":"10.1053\/berh.2001.0223_RF33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0163-8343(88)90085-0","article-title":"Mood effects of alternate day corticosteroid therapy in patients with systemic lupus erythematosus","volume":"10","author":"Joffe","year":"1988","journal-title":"General Hospital Psychiatry"},{"key":"10.1053\/berh.2001.0223_RF34","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/0002-9343(75)90500-8","article-title":"Central nervous system disease in systemic lupus erythematosus","volume":"58","author":"Sergent","year":"1975","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2001.0223_RF35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1177\/096120339900800609","article-title":"Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI","volume":"8","author":"Formiga","year":"1999","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF36","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1191\/096120399678847786","article-title":"Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus","volume":"8","author":"Carre\u00f1o","year":"1999","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF37","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s004150050436","article-title":"Cerebral computed tomography compared with neuropsychological findings in systemic lupus erythematosus","volume":"246","author":"Waterloo","year":"1999","journal-title":"Journal of Neurology"},{"key":"10.1053\/berh.2001.0223_RF38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11940-000-0045-7","article-title":"Neuropsychiatric systemic lupus erythematosus","volume":"2","author":"Navarrete","year":"2000","journal-title":"Curr Treat Options Neurol"},{"key":"10.1053\/berh.2001.0223_RF39","first-page":"1061","article-title":"A prospective study of neurophysiologic, neurologic and immunologic abnormalities in systemic lupus erythematosus","volume":"21","author":"McNicholl","year":"1994","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF40","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2169\/internalmedicine.38.729","article-title":"Systemic lupus erythematosus demonstrating serum anti-GM1 antibody with sudden onset of drop foot as the initial presentation","volume":"38","author":"Matsuki","year":"1999","journal-title":"Internal Medicine"},{"key":"10.1053\/berh.2001.0223_RF41","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0002-9343(00)00603-3","article-title":"Predictors of clinical outcome and radiologic progression in patients with neuropsychiatric manifestations of systemic lupus erythematosus","volume":"109","author":"Karassa","year":"2000","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2001.0223_RF42","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/096120339300200505","article-title":"Systemic lupus erythematosus in Greece. Clinical features, evolution and outcome: a descriptive analysis of 292 patients","volume":"2","author":"Vlachoyiannopoulos","year":"1993","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1136\/ard.57.8.456","article-title":"Systemic lupus erythematosus in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults","volume":"57","author":"Font","year":"1998","journal-title":"Annals of Rheumatic Diseases"},{"key":"10.1053\/berh.2001.0223_RF44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1007\/BF02207936","article-title":"Systemic lupus erythematosus: Clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE","volume":"14","author":"Antolin","year":"1995","journal-title":"Clinical Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0002-9343(99)80188-0","article-title":"Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus","volume":"99","author":"Toubi","year":"1995","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2001.0223_RF46","first-page":"1","article-title":"Lupus","volume":"2","author":"Duriseti","year":"2001","journal-title":"Medicine Journal"},{"key":"10.1053\/berh.2001.0223_RF47","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1191\/096120301678646191","article-title":"Systemic lupus erythematosus in Aborigines and Caucasians in Central Australia: a comparative study","volume":"10","author":"Segasothy","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1191\/096120398678919723","article-title":"Clinical profile of patients with late-onset SLE: not a benign subgroup","volume":"7","author":"Mak","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00286136","article-title":"Systemic lupus erythematosus in Chinese: the Singapore experience","volume":"2","author":"Feng","year":"1982","journal-title":"Rheumatology International"},{"key":"10.1053\/berh.2001.0223_RF50","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.50.7.490","article-title":"High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus","volume":"50","author":"Samanta","year":"1991","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2001.0223_RF51","first-page":"22","article-title":"The effect of race on the presentation and course of SLE in the United States","volume":"7","author":"Petri","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF52","first-page":"55","article-title":"IgA anticardiolipin and anti-\u03b22-glycoprotein I are the most prevalent isotypes in African American patients with systemic lupus erythematosus","volume":"318","author":"Cucurull","year":"1999","journal-title":"American Journal of Medical Science"},{"key":"10.1053\/berh.2001.0223_RF53","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.1780390907","article-title":"Association of anti-ribosomal P protein antibodies with neuropsychiatric systemic lupus erythematosus","volume":"39","author":"Isshi","year":"1996","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0002-9343(99)80135-1","article-title":"Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests","volume":"99","author":"West","year":"1995","journal-title":"American Journal of Medicine"},{"key":"10.1053\/berh.2001.0223_RF55","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1136\/ard.59.12.975","article-title":"Anti-ribosomal P protein antibodies detected by immunoblotting in patients with connective tissue diseases: their specificity for SLE and association with IgG anticardiolipin antibodies","volume":"59","author":"Ghirardello","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2001.0223_RF56","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s004150050006","article-title":"The contribution of fast-FLAIR MRI for lesion detection in the brain of patients with systemic autoimmune diseases","volume":"247","author":"Rovaris","year":"2000","journal-title":"Journal of Neurology"},{"key":"10.1053\/berh.2001.0223_RF57","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1093\/rheumatology\/34.11.1055","article-title":"Magnetic resonance of the brain in systemic lupus erythematosus","volume":"34","author":"Gonzalez-Crespo","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF58","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1529-0131(199901)42:1<61::AID-ANR8>3.0.CO;2-9","article-title":"Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging","volume":"42","author":"Kao","year":"1999","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/ard.59.5.377","article-title":"Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET","volume":"59","author":"Weiner","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1053\/berh.2001.0223_RF60","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/BF00879668","article-title":"Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: a controlled positron emission tomography study","volume":"24","author":"Otte","year":"1997","journal-title":"European Journal of Nuclear Medicine"},{"key":"10.1053\/berh.2001.0223_RF61","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/jon199993160","article-title":"Regional cerebral blood flow in patients with systemic lupus erythematosus","volume":"9","author":"Shen","year":"1999","journal-title":"Journal of Neuroimaging"},{"key":"10.1053\/berh.2001.0223_RF62","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1191\/096120398678919651","article-title":"Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study","volume":"7","author":"Otte","year":"1998","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF63","first-page":"81","article-title":"Relationship between neurometabolite derangement and neurocognitive dysfunction in systemic lupus erythematosus","volume":"26","author":"Brooks","year":"1999","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF64","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1161\/01.STR.29.11.2254","article-title":"Neurometabolite markers of cerebral injury in the antiphospholipid antibody syndrome of systemic lupus erythematosus","volume":"29","author":"Sabet","year":"1998","journal-title":"Stroke"},{"key":"10.1053\/berh.2001.0223_RF65","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1177\/155005940103200105","article-title":"Lateralized EEG findings in patients with neuropsychiatic manifestations of systemic lupus erythematosus","volume":"32","author":"Glanz","year":"2001","journal-title":"Clinical Electroencephalography"},{"key":"10.1053\/berh.2001.0223_RF66","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11926-001-0020-7","article-title":"Neuropsychiatric lupus","volume":"3","author":"Hanly","year":"2001","journal-title":"Current Rheumatology Reports"},{"key":"10.1053\/berh.2001.0223_RF67","first-page":"732","article-title":"Brain pathology in systemic lupus erythematosus","volume":"19","author":"Hanly","year":"1992","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1780390103","article-title":"Pathology and pathogenesis of vascular injury in systemic lupus erythematosus: interactions of inflammatory cells and activated endothelium","volume":"39","author":"Belmont","year":"1996","journal-title":"Arthritis & Rheumatism"},{"key":"10.1053\/berh.2001.0223_RF69","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/00002281-199609000-00007","article-title":"Prognosis and treatment of systemic lupus erythematosus","volume":"8","author":"Gladman","year":"1996","journal-title":"Current Opinion in Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF70","first-page":"1259","article-title":"Mortality studies in systemic lupus erythematosus. Results from a single center","volume":"22","author":"Abu-Shakra","year":"1995","journal-title":"Journal of Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00005792-199603000-00005","article-title":"Remission of systemic lupus erythematosus","volume":"2","author":"Drenkard","year":"1996","journal-title":"Medicine"},{"key":"10.1053\/berh.2001.0223_RF72","first-page":"55","article-title":"The accuracy of diagnosing neuropsychiatric lupus erythematosus in a series of 49 hospitalized patients","volume":"17","author":"Rood","year":"1999","journal-title":"Clinical and Experimental Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF73","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.1191\/096120301673275701","article-title":"Systemic lupus erythematosus as a chronic disease: Long-term follow up of 199 patients during 20 years","volume":"10","author":"Egurbide","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF74","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/rheumatology\/38.10.953","article-title":"Systemic lupus erythematosus: clinical features in patients with a disease duration of over 10 years, first evaluation","volume":"38","author":"Swaak","year":"1999","journal-title":"Rheumatology"},{"key":"10.1053\/berh.2001.0223_RF75","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1191\/096120301666282314","article-title":"Systemic lupus erythematosus. Disease outcome in patients with disease duration of at least 10 years: second evaluation","volume":"10","author":"Swaak","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF76","first-page":"135","article-title":"Old treatment \u223c new treatment, special issue","volume":"10","author":"Shoenfeld","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-857X(05)70145-9","article-title":"New therapies for systemic lupus erythematosus","volume":"26","author":"Strand","year":"2000","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"10.1053\/berh.2001.0223_RF78","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0889-857X(05)70142-3","article-title":"Dehydroepiandrosterone in systemic lupus erythematosus","volume":"26","author":"van Vollenhoven","year":"2000","journal-title":"Rheumatic Diseases Clinics of North America"},{"key":"10.1053\/berh.2001.0223_RF79","first-page":"S51","article-title":"Dehydroepiandrosterone improves cognitive function in patients with systemic lupus erythematosus: Results of a double-blinded, placebo controlled pilot study","volume":"10","author":"van Vollenhoven","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF80","first-page":"S34","article-title":"Controlled clinical trial of cyclophosphamide vs. methylprednisolone in severe neurologic manifestations in SLE","volume":"10","author":"Barile","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF81","first-page":"S104","article-title":"Cyclophosphamide in systemic lupus erythematosus: Cumulative dose and adverse events","volume":"10","author":"Bellomio","year":"2001","journal-title":"Lupus"},{"key":"10.1053\/berh.2001.0223_RF82","unstructured":"Trevisani, V, F, Castro, A, A, Neves-Neto, J, F, Atallah, A, N, Cyclophosphamide versus methylprednisolone for the treatment of neuropsychiatric involvement in systemic lupus erythematosus, The Cochrane Library"},{"key":"10.1053\/berh.2001.0223_RF83","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0140-6736(00)02627-1","article-title":"Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and hematopoietic stem-cell transplantation: A phase I study","volume":"356","author":"Traynor","year":"2000","journal-title":"Lancet"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694201902232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694201902232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T22:52:29Z","timestamp":1555023149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694201902232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,4]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,4]]}},"alternative-id":["S1521694201902232"],"URL":"https:\/\/doi.org\/10.1053\/berh.2001.0223","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2002,4]]}}}